BeOne Medicines AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,674	5,343	3,810	2,459	1,416	1,176
Revenue Growth	36.75%	40.23%	54.96%	73.65%	20.37%	280.83%
Cost of Revenue	670.75	668.54	594.09	379.92	286.48	164.91
Gross Profit	5,003	4,674	3,216	2,079	1,129	1,011
Selling, General & Admin	2,177	2,081	1,831	1,508	1,279	990.12
Depreciation & Amortization Expenses	-	-	-	-	-	0.75
Research & Development	2,205	2,146	1,953	1,779	1,641	1,459
Total Operating Expenses	4,383	4,227	3,784	3,287	2,919	2,450
Operating Income	685.94	447.14	-568.2	-1,208	-1,790	-1,439
Interest Income	-	70.51	69.64	-	-	-
Interest Expense	32.89	-58.23	-21.81	-4.36	-	-
Other Non-Operating Income (Expense)	1.33	-42.55	-12.64	386.26	-171.37	0.15
Total Non-Operating Income (Expense)	34.22	-30.28	35.2	381.9	-171.37	0.15
Pretax Income	655.17	416.85	-533	-825.84	-1,961	-1,439
Provision for Income Taxes	142.15	129.92	111.79	55.87	42.78	19.23
Net Income	513.02	286.93	-644.79	-881.71	-2,004	-1,458
Net Income to Common	513.02	286.93	-644.79	-881.71	-2,004	-1,458
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	110	109	105	104	103	93
Shares Outstanding (Diluted)	115	113	105	104	103	93
Shares Change	7.05%	7.75%	0.86%	1.22%	11.15%	11.16%
EPS (Basic)	4.81	2.60	-6.11	-8.45	-19.37	-15.73
EPS (Diluted)	4.29	2.47	-6.11	-8.45	-19.37	-15.73
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	1,115	941.74	-633.29	-1,719	-1,822	-1,562
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	9.73	8.30	-6.01	-16.47	-17.67	-16.83
Gross Margin	88.18%	87.49%	84.41%	84.55%	79.77%	85.98%
Operating Margin	12.09%	8.37%	-14.91%	-49.12%	-126.40%	-122.31%
Profit Margin	9.04%	5.37%	-16.92%	-35.86%	-141.52%	-123.93%
FCF Margin	19.64%	17.63%	-16.62%	-69.93%	-128.68%	-132.76%
EBITDA	835.96	588.82	-396.44	-1,120	-1,723	-1,392
EBITDA Margin	14.73%	11.02%	-10.40%	-45.55%	-121.71%	-118.36%
EBIT	685.94	447.14	-568.2	-1,208	-1,790	-1,439
EBIT Margin	12.09%	8.37%	-14.91%	-49.12%	-126.40%	-122.31%
Effective Tax Rate	21.70%	31.17%	-20.97%	-6.77%	-2.18%	-1.34%

SEC Filings: 10-K · 10-Q